VTVT (vTv Therapeutics Inc) Future Price to Earnings

Corporate emblem and logo of vTv Therapeutics, Inc. (VTVT)

vTv Therapeutics Inc. (VTVT) is a small-molecule innovator for type 1 diabetes therapy with strong scientific potential. The issuer's expected P/E on GURU.Markets illustrates the valuation trend, where the parameter value equals 0.00. The company's revenues are based on partnerships and the future commercialization of drugs. Currently, the biotech firm is preparing for key tests, focusing on external financing without altering its capital structure.

VTVT - vTv Therapeutics Projected Price to Earnings Ratio over the range 07/04/2022 - 11/18/2026

Analytical breakdowns for vTv Therapeutics Inc.

- current price and projected stock value:
General company analysis:VTVT vTv Therapeutics
Brand item of vTv Therapeutics Inc

Forward P/E measures the ratio of market capitalization to projected net income, making the metric extremely sensitive to any changes in operating expenses and future revenues. Amid intense pressure from pharmaceutical behemoths in the diabetes market, analyzing the shift in the future P/E level of vTv Therapeutics Inc. (VTVT) allows investors to distinguish a fair undervaluation of vTv Therapeutics Inc. (VTVT) from "value trap" risks driven by aggressive competition.

Competitors of vTv Therapeutics Inc. (VTVT)

Projected Price to Earnings ASND (Ascendis Pharma Inc.)|MDGL (Madrigal Corp) - Future Price to Earnings Multiple|Future Price to Earnings corcept.com CORT|RYTM - Projected Price to Earnings|Akero Corp - Forward P/E Multiple|Projected Price to Earnings Ratio Metsera Corp|MLTX (MoonLake) - Projected Price to Earnings|CRNX: Market Cap to Future Earnings Ratio|NAMS (NewAmsterdam Pharma Corp) - Forward P/E Multiple|Forward P/E Multiple Soleno Therapeutics|Forward P/E Multiple FOLD|Future Price to Earnings ETNB (89bio Inc)|Future Price to Earnings agios.com AGIO|Structure Corp (GPCR) - Projected Price to Earnings Ratio|MDXG - Future Price to Earnings|RZLT: Future Price to Earnings|LXRX: Forward P/E Multiple|MBX - Market Cap to Projected Earnings|Future Price to Earnings Altimmune Pharma|Aardvark Pharma (AARD) - Market Cap to Projected Earnings|Future Price to Earnings sagimet.com (SGMT)|Projected Price to Earnings BioAge Labs, Inc. BIOA|Forward P/E Multiple BMEA (Biomea Fusion)|Forward Price to Earnings Multiple quincetx.com|GUTS - Future Price to Earnings|Forward Price to Earnings Multiple agapeatpgroup.com (ATPC)|PLUR (Pluri) - Projected Price to Earnings|Price to Future Earnings Ratio SYBX|Future Price to Earnings Lipocine Corporation|matinasbiopharma.com (MTNB) - Market Cap to Projected Earnings|Forward P/E Multiple SPRB|Projected Price to Earnings Galecto, Inc. GLTO|Future Price to Earnings Carmell Corporation CTCX|Future Price to Earnings Multiple LUMO|ONVO: Projected Price to Earnings|Future Price to Earnings Multiple RDUS (Radius Recycling Inc.)